资讯

AI医药领域新机遇：Recursion Pharmaceuticals上涨近23%引领市场
在科技飞速进步的今天，人工智能（AI）正在悄然改变各个领域，尤其是在医药研发方面。最近，Recursion Pharmaceuticals（RXRX.US）等AI医药开发概念股的股价大幅上涨，吸引了投资者的目光。根据智通财经APP的报道，Recursion Pharmaceuticals的股价上涨近23%，而Certara（CERT.US）和Simulations Plus（SLP.US）也分别上 ...
Trump threatens to end pharmaceuticals tariff exemption
The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.
Trump pledges tariffs on pharmaceuticals, setting up fight over who pays
President Trump’s threatened tariffs could lead to higher out-of-pocket costs or insurance premiums, depending on whether ...
STAT8 天
Pharmaceuticals are spared from tariffs, for now
President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries ...
Trump says 'major tariff' coming soon on foreign pharmaceuticals
Trump predicted a tariff on foreign pharmaceuticals will prompt drug companies to move their operations to the United States.
Pharmaceuticals tariffs up next: Donald Trump's big announcement amid market turmoil
Former President Donald Trump announced a major new tariff on pharmaceutical imports to encourage drug manufacturers to ...
Recursion Pharmaceuticals price target lowered to $8 from $10 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Recursion Pharmaceuticals (RXRX) to $8 from $10 and keeps an Equal Weight rating on the ...
Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise
GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...